1. Introduction {#sec1}
===============

Schistosomiasis is one of the most widely occurring neglected tropical diseases, with high incidence in Asia, Africa and Latin America. About 207 million people have been infected worldwide and 780 million people are at risk of infection, and more than 240 million patients require treatment each year ([@bib2], [@bib15]). *Schistosoma japonicum* (*S. japonicum*) is the major causative agent in Southeast Asia and China. The presence of eggs from *S. japonicum* in the host liver and intestinal tissue is the major cause of pathologic schistosomiasis. During infection, schistosome eggs are trapped in the host liver and stimulate the granulomatous response. Subsequent significant fibrosis and circulatory impairment can develop in a subset of individuals with extensive or repeated infection and/or lack of treatment ([@bib20]). Hepatic fibrosis is the principal cause of morbidity and mortality in humans with schistosome infection. However, effective medical interventions to control and treat granuloma and fibrosis in schistosomiasis are lacking.

Granulomatous reaction of schistosome is the CD4^+^ T cell-mediated delayed-type hypersensitivity induced by soluble egg antigen secreted from viable miracidium within eggs trapped in host tissues. The formation of granulomas is a dynamic process that involves the accumulation of inflammatory and immune cells at the site of antigen release, leading to the confinement of the eliciting agent ([@bib4]). Toward the late stage, fibroblasts are stimulated by egg products and by T-lymphocyte cytokines to proliferate, replacing most of the cellular elements and mediating fibrotic collagenous material deposition around the portal vein tributaries ([@bib24]). Many factors are involved in regulating the immunopathogenesis of schistosomiasis. T helper 1 cell (Th1) and Th2 cytokines determine the hepatic granuloma size ([@bib20], [@bib4]), and Th17 responses have been linked with severe hepatic inflammation in schistosomiasis ([@bib4]). Chemokines, particularly macrophage inflammatory protein 1α (MIP-1α) and monocyte chemotactic protein 1α (MCP-1α), play major roles in the formation of hepatic granuloma. Mice deficient in MIP-1α show decreased hepatic granuloma size and both fibrosis and eosinophil peroxidase activity ([@bib29]). MCP-1α, can be produced by activated hepatic stellate cells (HSCs) following liver injury, showed increased transcriptional levels during *S. japonicum* infection correlates with peak fibrosis ([@bib1]). Transforming growth factor-β1 (TGF-β1) is the most potent fibrogenic cytokine in the liver. TGF-β1 activates and transforms HSCs into myofibroblast-like cells, which express a-smooth muscle actin (a-SMA) and secrete collagens containing hydrohyproline that form extracellular matrix (ECM) fibrosis ([@bib12], [@bib30]). In addition, pro-inflammatory stimulation, oxidative stress and tissue damage may play important roles in schistosomiasis ([@bib5], [@bib7]).

Taurine (2-aminoethane sulfonic acid), a sulfur-containing β-amino acid, is ubiquitously distributed in animal tissues and cells, accounts for approximately 0.1% of total human body weight. It is both synthesized endogenously from cysteine and methionine and ingested directly with certain foodstuffs. According to the European Food Safety Authority, taurine (3--6 g) has been administered daily to a large number of patients (including adults, children and even infants). No adverse health effects have been noted ([@bib28]). In recent years taurine has been widely used as a performance-enhancing ingredient in energy drinks ([@bib21]). In general, oral taurine can be absorbed by gastrointestinal tract, plasma proteins combination with taurine are fewer. Taurine discharges mainly in prototype and kidney can adjust the content of taurine in the body. The normal concentration of taurine in the plasma is very low (e.g.\<60 μM in cat) but most tissues contain very high taurine levels (mM range), creating a substantial concentration gradient across the cell membrane ([@bib28]). The half-life of turnover of taurine in the mouse was 18.6 days ([@bib16]). Taurine has various physiological functions and protective properties including protection against various types of hepatic damage ([@bib14]). In addition, taurine possesses anti-inflammatory and immunoregulatory properties ([@bib6]). Previous studies have demonstrated that exogenous supplementation with taurine can prevent liver injury caused by different harmful substances as well as inhibit ECM deposition on the damaged liver and stop the process of liver fibrosis ([@bib23], [@bib10], [@bib11], [@bib14]). Mice with hetero- and homozygous knockout of the taurine transporter show chronic liver disease characterized by fibrosis, inflammation, and hepatocyte apoptosis ([@bib32]). The hepatoprotective effects of taurine are often accompanied by reduced endoplasmic reticulum (ER) stress, oxidative stress, production of inflammatory and fibrogenic mediators and activation of stellate cells ([@bib13], [@bib11], [@bib14]). However, whether taurine supplementation can affect the pathological processes of hepatic granulomas and fibrosis elicited by *S. japonicum* infection is not known.

In this paper, we aimed to determine the effect of taurine supplementation on granuloma formation and the fibrosis process in an animal model of *S. japonicum* infection to assess its potential as preventative and therapeutic treatment for schistosomiasis. [@bib22] reported that the effective and optimal doses of oral taurine administration for two weeks on a transient exercise performance in rat were between 100 and 500 mg/kg/day. Various reports have described the experimental use of taurine supplemented in drinking water in mice over the concentration range of 0.05%∼5% ([@bib25], [@bib26], [@bib27]). Hence, we used 1% taurine supplementation in our experiment. We found that taurine supplementation could suppress *S. japonicum* egg-induced liver granuloma and fibrosis in mice.

2. Materials and methods {#sec2}
========================

2.1. Parasite and animals {#sec2.1}
-------------------------

*S. japonicum* (Chinese mainland strain)-infected *Oncomelania hupensis* snails were purchased from the Jiangsu Institute of Parasitic Diseases (Wuxi, Jiangsu, China). Female ICR mice, 6--8 weeks old, were from the Department of Laboratory Animal Science of Peking University Health Science Center (Beijing). All animal care and experimental protocols complied with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication, 8th Edition, 2011) and were approved by the Animal Care Committee of Peking University Health Science Center.

2.2. Infection of mice with *S. japonicum* {#sec2.2}
------------------------------------------

*S. japonicum* cercariae were shed in a beaker after exposing infected *Oncomelania* to light for 6 h in 24--28 °C. The mice were infected percutaneously with 30 ± 2 freshly shed cercariae after they had been anesthetized by intraperitoneal injection of ketamine.

2.3. Experimental group and taurine treatment {#sec2.3}
---------------------------------------------

Mice were randomly divided into three groups for treatment (10 mice per group): 1) control (Con), mice not infected with *S. japonicum* and fed standard chow; 2) infected (Inf), mice infected with *S. japonicum* and fed standard chow; 3) infected/taurine (Tau), mice infected with *S. japonicum*, fed standard chow and 1% taurine (Sigma, MO, USA) in drinking water for 4 weeks starting at 4 weeks post-infection. At 8 weeks post-infection, the body weight of each mouse was weighed and serum was separated from blood taken from the mouse eye socket, then mice were killed by cervical dislocation, and liver tissue and serum samples were collected for analysis.

2.4. Liver and spleen indexes, egg burden {#sec2.4}
-----------------------------------------

The liver and spleen tissue was weighed. Liver and spleen indexes were calculated as ratios of liver to body weight and spleen to body weight, respectively.

To determine the egg burden, 1 g of each liver was digested with 5% KOH at 37 °C overnight. After centrifugation, released eggs in the liver were then determined by microscopic examination.

2.5. Analysis of liver transaminase activity {#sec2.5}
--------------------------------------------

Liver injury was assessed by measuring serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) by use of an Olympus AU5800 automatic biochemical analyzer (Olympus, Japan).

2.6. Histology and immunohistochemistry (IHC) of liver sections {#sec2.6}
---------------------------------------------------------------

Excised livers were instantly fixed in 10% neutral formalin overnight and embedded in paraffin. For histology, according to standard procedures, tissue sections (4 μm) were stained with hematoxylin and eosin (H&E) to examine the area of the granulomas or with Masson trichrome to evaluate the extent of hepatic fibrosis. Granuloma formation and fibrosis were analyzed under a Leica DMI 3000B fluorescence microscope. The granulomatous area as a percentage of total area for each side was measured by computer-assisted morphometric software (Leica Application Suite 4.1). For each specimen, at least three non-contiguous slides were measured and the mean values from 6 to 8 mice for each group were used for statistical analysis.

Tissue underwent immunostaining for anti-α-SMA antibody, a marker of HSC activation, and glucose-regulated protein 78 (GRP78), an ER stress marker (Abcam, Cambridge, UK). Six to 10 microphotographs per mouse liver were recorded under an inverted microscope (Leica DMI 3000B). At least three non-contiguous tissue sections were measured, and the mean values from 6 to 8 mice were used for statistical analysis.

2.7. Quantitative PCR {#sec2.7}
---------------------

Total RNA was extracted from liver tissue of each mouse by use of Trizol Reagent (Applygen Technologies, Beijing). In total, 1 μg RNA was reverse-transcribed to cDNA by use of the PrimeScript RT reagent kit (TaKaRa Biotechnology, Dalian, China). Real-time PCR experiments were performed in triplicate with SYBR *premix Ex TaqTM* Ⅱ (TaKaRa Biotechnology) on an ABI 7500 Fast Real-Time PCR System (Applied Biosystems, Fullerton, CA). The PCR primers were designed by use of the Primer-BLAST tool on the NCBI website; data on primers are in [Table 1](#tbl1){ref-type="table"}. Levels of target genes were normalized to that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a housekeeping gene ([@bib17], [@bib31]). Relative mRNA expression was analyzed by use of Applied Biosystems 7500 Software and calculated by the comparative Ct method with the formula 2^−△△Ct^.

2.8. Statistical analysis {#sec2.8}
-------------------------

Results were presented as mean ± SEM. Statistical analysis involved use of GraphPad Prism 5 for Windows (GraphPas Software, San Diego, CA, USA). One-way and two-way ANOVA was used to for analysis. *P* \< 0.05 was considered statistically significant.

3. Results {#sec3}
==========

3.1. Taurine treatment improves the gross appearance and decreases liver and spleen indexes of *S. japonicum*-infected mice {#sec3.1}
---------------------------------------------------------------------------------------------------------------------------

After infection of *S. japonicum*, infected mice showed typical manifestations, including diarrhea and athrepsia. The survival rates of infected and infected/taurine-treated groups were 60% and 80%, respectively, at 8 weeks post-infection, and hence, subsequent data collection involved less than the 10 mice initially allocated to each treatment group.

To evaluate the general effect of taurine on the pathologic features of *S. japonicum*-infected mice, control, infected and infected/taurine-treated mice were weighed and killed, the gross appearance of liver and spleen was observed, and liver and spleen indexes were measured. Normal livers were light red with a smooth surface after blood removal, whereas infected livers were darker red, with many small white spots on the surface, indicating many granuloma nodules. Livers from taurine-treated mice showed an improved appearance over infection alone and fewer white spots ([Fig. 1](#fig1){ref-type="fig"}A). The size of spleen increased greatly at 8 weeks post-infection, and taurine treatment attenuated this increase ([Fig. 1](#fig1){ref-type="fig"}A). In addition, body weight was lower in infected than control mice but was slightly higher with taurine treatment than with infection alone (data not shown). Liver and spleen indexes were higher for infected than control mice (all p \< 0.01) ([Fig. 1](#fig1){ref-type="fig"}B). Accordingly, taurine treatment attenuated this increase (p \< 0.05 and p \< 0.01, respectively). Therefore, taurine treatment improved the gross appearance of livers and decreased liver and spleen indexes of *S. japonicum*-infected mice.

3.2. Taurine treatment attenuates hepatic injury of *S. japonicum*-infected mice {#sec3.2}
--------------------------------------------------------------------------------

We further evaluated the effect of taurine on the hepatic injury of *S. japonicum*-infected mice. The serum ALT and AST levels were higher in infected than control mice (p \< 0.05 and p \< 0.01, respectively) and were lower with taurine treatment than with infection alone ([Fig. 2](#fig2){ref-type="fig"}, all p \< 0.05). Hence, taurine treatment may attenuate the hepatic injury of *S. japonicum*-infected mice.

3.3. Egg burden is similar in taurine treated and untreated mice infected with *S. japonicum* {#sec3.3}
---------------------------------------------------------------------------------------------

The soluble egg antigen secreted by matured schistosome miracidium within eggs is believed to cause a granulomatous response, so egg load in liver determines the severity of liver pathology. We evaluated the egg burden of liver in taurine treated and untreated mice infected with *S. japonicum*. Result showed similar liver egg burden between taurine treated and untreated mice ([Fig. 3](#fig3){ref-type="fig"}). This result implies that taurine treatment can not affect the deposition of eggs on the liver and the ameliorative effect of taurine on hepatic injury is not caused by difference in schistosome egg.

3.4. Taurine treatment suppresses *S. japonicum* egg-induced liver granuloma formation {#sec3.4}
--------------------------------------------------------------------------------------

Liver granulomas and fibrosis are the pathological hallmarks of schistosome infection. To investigate the effect of taurine on *S. japonicum* egg-induced liver granuloma, H&E staining of liver sections was used to analyze the proportion of granulomatous area. Control livers showed normal cellular organization of uninfected hepatic lobules, with the typical actinomorphous distribution of hepatic cords around central veins ([Fig. 4](#fig4){ref-type="fig"}A). Infected livers showed markedly altered histological structure. At 8 weeks post-infection, inflammatory granulomatous lesions were seen in the liver tissue around schistosome eggs ([Fig. 4](#fig4){ref-type="fig"}B). Taurine treatment markedly reduced the number and diameter of granulomas ([Fig. 4](#fig4){ref-type="fig"}C). Compared with infected mice, taurine-treated mice showed significantly decreased proportion of liver granulomatous area ([Fig. 4](#fig4){ref-type="fig"}D; p \< 0.01).

3.5. Taurine treatment reduces *S. japonicum* egg-induced liver fibrosis {#sec3.5}
------------------------------------------------------------------------

Liver fibrosis was evaluated by Masson trichrome staining and IHC staining for α-SMA protein. With Masson trichrome staining, the collagen fibers were stained blue, cell nuclei were stained black, and the background was stained red. Control mice showed normal collagen deposition with periportal few collagen. However, the amount of collagen fibers was significantly increased in infected liver, with most around granulomas. Compared with infection alone, taurine treatment decreased collagen deposition ([Fig. 5](#fig5){ref-type="fig"}A).

Activation of HSCs into fibroblasts is the key event in the process of liver fibrosis. Expression of α-SMA is commonly used as a hallmark of the activated HSCs. IHC staining for α-SMA revealed significantly increased amount of α-SMA^+^ cells in liver of infected mice but reduced with taurine treatment ([Fig. 5](#fig5){ref-type="fig"}B), which was consistent with the degree of fibrosis. Taurine treatment may reduce *S. japonicum* egg-induced liver fibrosis.

3.6. Taurine treatment decreases tumor necrosis factor α (TNF-α), TGF-β1, MCP-1α and MIP-1α mRNA levels {#sec3.6}
-------------------------------------------------------------------------------------------------------

To explore the molecular mechanism underlying the anti-granulomatous and anti-fibrotic effects with taurine supplementation, we analyzed the mRNA levels of several granulomatous and fibrogenic mediators in mice livers. Compared with control mice, infected mice showed increased levels of TNF-α, TGF-β1, MCP-1α and MIP-1α ([Fig. 6](#fig6){ref-type="fig"}, all p \< 0.01). However, taurine supplementation significantly decreased the levels of these cytokines/chemokines (p \< 0.05 for TGF-β1 and MCP-1α, p \< 0.01 for TNF-α and MIP-1α). The ameliorative effects of taurine supplementation on *S. japonicum* egg-induced hepatic granulomas and fibrosis may depend in part on the downregulation of these relevant cytokines/chemokines.

3.7. Taurine treatment markedly suppresses GRP78 level {#sec3.7}
------------------------------------------------------

ER stress plays an important role in the development and progression of liver fibrosis. Taurine is a well-known ER stress modulator that prevents abnormal protein aggregation and unfolded protein response. We examined the expression of the ER stress marker GRP78 in mouse liver by IHC staining and real-time PCR. GRP78 expression was greatly increased in livers of infected mice as compared with controls, and taurine supplementation markedly suppressed GRP78 expression ([Fig. 7](#fig7){ref-type="fig"}), which suggests that taurine attenuating the hepatic pathologic features of infected mice may involve modulating the ER stress response.

4. Discussion {#sec4}
=============

*S. japonicum* is one of the most common public health problems in China. Schistosome egg-induced hepatic granuloma formation can lead to tissue destruction and fibrosis, which causes much of the morbidity and mortality associated with this disease. Therefore, inhibiting schistosome egg-induced granuloma and subsequent fibrosis can prevent the development of the disease. Here, we found that taurine supplied in drinking water to mice may have significant potential as a preventative and therapeutic treatment to ameliorate hepatic injury and suppress hepatic granuloma formation and fibrosis during *S. japonicum* infection.

The formation of schistosome egg-induced hepatic granuloma is a dynamic process triggered by soluble egg antigen secreted from viable miracidium within eggs trapped in liver tissue. Because of the continuous antigenic stimulation from the trapped ova, inflammatory and immune cells are sequentially recruited to the sites of infection, thereby leading to the formation of periovular granulomas ([@bib4]). The liver gradually hardens and is filled with many granuloma nodules ([Fig. 1](#fig1){ref-type="fig"}A). As well, a severe granulomatous response precipitates fibrosis in the liver quickly and eventually causes extensive tissue scarring, which in turn causes severe circulatory impairment of the affected organs. So, granuloma formation is the essential pathological lesion of schistosomiasis, and blocking its formation is critical for the prognosis of disease. In the current study, taurine supplied in drinking water to mice reduced the elevated aminotransferase levels and improved the gross health state of *S. japonicum*-infected mice ([Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}). Although taurine supplementation could not reduce the egg burden in liver ([Fig. 3](#fig3){ref-type="fig"}), it suppressed granuloma formation induced by *S. japonicum* eggs ([Fig. 4](#fig4){ref-type="fig"}). We confirmed that taurine has hepatoprotective effects and can inhibit granuloma formation in schistosome infection.

During the chronic phase of infection, collagen is increasingly deposited in the host liver and fibrosis develops. HSCs are one of the main sources of collagen in the liver and play crucial roles in schistosome-induced fibrogenesis. Quiescent HSCs primarily function to store vitamin A, but in response to liver tissue injury, they are activated and transdifferentiate into myofibroblasts, characterized by the production of ECM components rich in fibrillar collagens ([@bib4]). Activated HSCs are located at the edges of hepatic granulomas in mice infected with *S. japonicum*, as shown by IHC staining for the HSC marker a-SMA. Because of increased collagen deposition and portal hypertension, liver function is further damaged, which leads to liver cirrhosis. Fibrosis is reversible, but cirrhosis is irreversible, so fibrosis progressing to cirrhosis must be prevented. Previous studies have demonstrated that taurine can inhibit the deposition of the ECM in the damaged liver and the proliferation of HSC ([@bib3]). Oral taurine administration enhances hepatic taurine accumulation, reduces oxidative stress and prevents the progression of hepatic fibrosis in rats with carbon tetracholoride-induced hepatic damage and inhibits the transformation of HSCs ([@bib23]). In addition, natural taurine can promote HSC apoptosis to inhibit hepatic fibrosis ([@bib9]). Consistent with these results, our studies showed that taurine supplementation could ameliorate *S. japonicum*-induced hepatic fibrosis ([Fig. 5](#fig5){ref-type="fig"}).

The initiation, development, and regression of hepatic granuloma and fibrosis is mediated by the communication of many cytokines and chemokines. Studies *in vitro* and in experimental models *in vivo* have demonstrated that TNF-a plays a role in granuloma formation and hepatic fibrosis. In fact, TNF-a seems to play a central role in promoting periportal fibrosis during *Schistosoma mansoni* infection and was found to be elevated in peripheral blood eosinophils from chronic *S. mansoni*-infected patients ([@bib8]). TGF-β1 is the most potent fibrogenic cytokine in the liver; its expression is increased during fibrogenesis and it is the dominant stimulus inducing HSCs to increase ECM synthesis ([@bib12]). Taurine can promote apoptosis in HSCs by inhibiting the expression of TGF-β1, thereby blocking the TGF-β1/Smad pathway, a canonical pathway that can potently regulate hepatic fibrogenesis ([@bib33], [@bib19]). In addition, chemokine MCP-1a can trigger migration of monocytes into hepatic granulomas. To that effect, the expression profile of MCP-1a is closely correlated with granuloma diameter and egg burden, so the molecule may play a key role in initiating and maintaining the immune response to tissue egg deposition ([@bib1]). MIP-1α is a marker of disease severity in schistosome-infected humans, and experimental studies in mice suggest that MIP-1α may be a causative factor in the development of severe schistosomiasis ([@bib29]). We found that taurine supplementation could downregulate these granulomatous and fibrogenic mediators in the liver of *S. japonicum*-infected mice ([Fig. 6](#fig6){ref-type="fig"}), which further confirmed the anti-granulomatous and anti-fibrotic effects of taurine during *S. japonicum* infection.

ER stress plays an important role in the development and progression of liver fibrosis ([@bib18]). The beneficial effects of taurine are often accompanied by reduced ER stress, which suggests a link between the therapeutic properties of taurine and restoration of ER homeostasis. Taurine mitigated palmitate-induced ER stress and cell death in primary hepatocytes and H4IIE liver cells; part of the protective effects of taurine in diet-induced nonalcoholic fatty liver disease were related to the amelioration of ER stress ([@bib14]). To further determine the underlying mechanisms of taurine improving the hepatic pathologic features of *S. japonicum-*infected mice, we studied the effect of taurine supplementation on the expression of the ER stress marker GRP78 in the liver of infected mice. Taurine supplementation markedly suppressed GRP78 expression in the liver of infected mice ([Fig. 7](#fig7){ref-type="fig"}), which suggested that taurine attenuating the hepatic pathologic features of *S. japonicum*-infected mice may be related in part to its modulation of the ER stress response. However, the exact mechanism still needs further investigation.

In conclusion, taurine supplementation could reduce hepatic lesions and restrain granuloma formation and resultant fibrosis in *S. japonicum-*infected mice by downregulating granulomatous and fibrogenic mediators and alleviating ER stress response. Taurine may have significant potential as a preventative and therapeutic treatment in *S. japonicum* infection.
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![Taurine improves the gross appearance and decreases liver and spleen indexes of *Schistosoma japonicum*-infected mice. ICR mice were infected percutaneously with 30 ± 2 *S. japonicum* cercaria. *S. japonicum*-infected mice were fed 1% taurine in drinking water for 4 weeks starting at 4 weeks post-infection. (A) Gross appearance of the liver and spleen of control, infected and infected/taurine-treated mice. (B) Liver and spleen indexes. Data are mean ± SEM of 6--10 mice/group. Con: control group; Inf: infected group; Tau: infected/taurine-treated group. \*p \< 0.05, \*\*p \< 0.01 vs Con; &: p \< 0.05, &&: p \< 0.01 vs Inf.](gr1){#fig1}

![Effect of taurine on the levels of serum transaminases (ALT/AST) of *S. japonicum*-infected mice. ICR mice were infected percutaneously with 30 ± 2 *S. japonicum* cercaria. *S. japonicum*-infected mice were fed 1% taurine in drinking water for 4 weeks starting at 4 weeks post-infection. Serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were measured by use of a biochemical analyzer. Data are mean ± SEM of 6--10 mice/group. Con: control group; Inf: infected group; Tau: infected/taurine-treated group. \*p \< 0.05, \*\*p \< 0.01 vs Con; &: p \< 0.05 vs Inf.](gr2){#fig2}

![Egg burden is similar in taurine treated and untreated mice infected with *S. japonicum*. ICR mice were infected percutaneously with 30 ± 2 *S. japonicum* cercaria. *S. japonicum*-infected mice were fed 1% taurine in drinking water for 4 weeks starting at 4 weeks post-infection. The number of eggs extracted from the liver was determined by microscopic examination. Data are given as mean ± SEM of 6--8 mice/group. Inf: infected group; Tau: infected/taurine-treated group. NS: no statistical significance.](gr3){#fig3}

![Taurine suppresses *S. japonicum* egg-induced liver granuloma formation. ICR mice were infected percutaneously with 30 ± 2 *S. japonicum* cercaria. *S. japonicum*-infected mice were fed 1% taurine in drinking water for 4 weeks starting at 4 weeks post-infection. H&E staining of liver sections in (A) control, (B) *S. japonicum*-infected and (C) infected/taurine-treated mice (original magnification 50 ×). Arrows indicate granulomatous lesions and arrowheads indicate schistosome eggs. (D) The granulomas area as a percentage of total area was measured by computer-assisted morphometric analysis. Data are mean ± SEM of 6--8 mice/group. Inf: infected group; Tau: infected/taurine-treated group. \*\*p \< 0.01 vs Inf.](gr4){#fig4}

![Taurine reduces *S. japonicum* egg-induced liver fibrosis. ICR mice were infected percutaneously with 30 ± 2 *S. japonicum* cercaria. *S. japonicum*-infected mice were fed 1% taurine in drinking water for 4 weeks starting at 4 weeks post-infection. Liver tissues were fixed and stained with Masson trichrome or anti-α-smooth muscle actin (SMA) antibody. (A) Masson trichrome staining for collagen content and distribution. Collagen fibers were stained blue, cell nuclei black, and background red (original magnification 50 ×). (B) Immunohistochemistry of expression of α-SMA protein in liver tissues (original magnification 200 ×). The quantitative changes were measured by computer-assisted morphometric analysis. Data are mean ± SEM of 6--8 mice/group. Con: control group; Inf: infected group; Tau: infected/taurine-treated group. \*p \< 0.05, \*\*p \< 0.01 vs Inf. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](gr5){#fig5}

![Taurine decreases transforming growth factor β1 (TGF-β1), tumor necrosis factor α (TNF-α), monocyte chemotactic protein 1α (MCP-1α) and macrophage inflammatory protein 1α (MIP-1α) mRNA levels. ICR mice were infected percutaneously with 30 ± 2 *S. japonicum* cercaria. *S. japonicum*-infected mice were fed 1% taurine in drinking water for 4 weeks starting at 4 weeks post-infection. Real-time quantitative PCR of liver tissue. Data are mean ± SEM of 6--8 mice/group. Con: control group; Inf: infected group; Tau: infected/taurine-treated group. \*p \< 0.05, \*\*p \< 0.01 vs Con; &: p \< 0.05, &&: p \< 0.01 vs Inf.](gr6){#fig6}

![Taurine suppresses the expression of endoplasmic reticulum (ER) stress marker glucose-regulated protein 78 (GRP78). ICR mice were infected percutaneously with 30 ± 2 *S. japonicum* cercaria. *S. japonicum*-infected mice were fed 1% taurine in drinking water for 4 weeks starting at 4 weeks post-infection. (A) Immunohistochemistry of protein expression of GRP78 in mouse liver tissue (Original magnification: left, 50 ×; right, 200 ×). (B) Quantitative PCR analysis of mRNA level of GRP78 in mouse liver tissue. Data are mean ± SEM of 6--8 mice/group. Con: control group; Inf: infected group; Tau: infected/taurine-treated group. \*\*p \< 0.01 vs Con; &: p \< 0.05 vs Inf.](gr7){#fig7}

###### 

Gene-specific primers used for quantitative real-time RT-PCR.

  ------------------------------------------------------------------------------------------------------------------------------
  Gene name   Primer sequences (5′→3′)      Annealing temp.(°C)   Length (bp)   Acc.No./ID
  ----------- ----------------------------- --------------------- ------------- ------------------------------------------------
  TNF-α       F: GCCCACGTCGTAGCAAACCACC\    60                    204           [NM_013693.2](ncbi-n:NM_013693.2){#intref0010}
              R: TCGGCTGACGGTGTGGGTGA                                           

  TGF-β1      F: AGCTGCGCTTGCAGAGATTA\      60                    180           [NM_011577.1](ncbi-n:NM_011577.1){#intref0015}
              R: TTCCGTCTCCTTGGTTCAGC                                           

  MIP-1α      F: CCATATGGAGCTGACACCCC\      60                    101           [NM_011337.2](ncbi-n:NM_011337.2){#intref0020}
              R: GAGCAAAGGCTGCTGGTTTC                                           

  MCP-1α      F: CAGATGCAGTTAACGCCCCA\      60                    116           [NM_011333.3](ncbi-n:NM_011333.3){#intref0025}
              R: AGCTTCTTTGGGACACCTGC                                           

  GRP78       F: ATCGTGCCTCTCATTGGTGG\      60                    149           [U16277.1](ncbi-n:U16277.1){#intref0030}
              R: TAGTTGGAGGCCGCTGATTG                                           

  GAPDH       F: ATGACATCAAGAAGGTGGTGAAG\   60                    238           [NM_008084.2](ncbi-n:NM_008084.2){#intref0035}
              R: TCCTTGGAGGCCATGTAGG                                            
  ------------------------------------------------------------------------------------------------------------------------------

F: forward; R: reverse; TNF-α: tumor necrosis factor-alpha; TGF-β1: transforming growth factor-beta 1; MIP-1α: macrophage inflammatory protein 1 alpha; MCP-1α: monocyte chemotactic protein 1 alpha; GRP78: 78 kDa glucose-regulated protein; GAPDH: glyceraldehyde-3-phosphate dehydrogenase.
